Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors at 1 institution in 1 country.
Kanupriya GuptaDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Howard W WienerDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0009-0009-7071-5531
Hemant K TiwariDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0003-4016-1856
William M GeislerDepartment of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
University of Alabama at Birmingham · US
Funding
National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
Mechanisms and Correlates of Immune Protection against Genital Chlamydia in HumansR01AI093692 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GEISLER, WILLIAM M · 2012 to 2023
$4.5M
NovaSeq 6000 Sequencing SystemS10OD032422 · OD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROWLEY, MICHAEL R · 2022 to 2022
$945k
Epigenetic Determinants and Mechanisms Influencing Genital Chlamydia trachomatis Reinfection in African American WomenR21AI156142 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GEISLER, WILLIAM M, TIWARI, HEMANT K. · 2021 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.